Analysis of 24-h urinary steroid excretion was performed by capillary gas chromatography in six patients (five men, one woman) with adrenocortical insufficiency. Ten healthy subjects (five men, five women) served as controls. A complete absence of all 21-hydroxylated steroid metabolites was seen in patients with adrenocortical insufficiency, whereas the excretion of several steroids lacking hydroxylation in the 21-position (pregnenolone, pregnenetriol, and 11-ketoandrosterone) was markedly increased. In addition, the presence of 11 beta-hydroxyandrosterone was confirmed by mass-spectrometry in the urine of three patients. This pattern of steroid excretion was unchanged in patients with adrenocortical insufficiency, both after stimulation by 1-24 adrenocorticotropin (ACTH) and after short-term (3-d) suppression with dexamethasone. We conclude that patients with adrenocortical insufficiency present a pattern of steroid excretion characterized by the absence of 21-hydroxylated metabolites. In the absence of functional adrenocortical tissue, long-term pathologically elevated concentrations of ACTH apparently stimulate early steps of steroid synthesis, most likely in the gonads. In addition, the presence of 11-hydroxylated steroid metabolites (11-ketoandrosterone, 11 beta-hydroxyandrosterone) in the urine of patients with adrenocortical insufficiency demonstrates that chronic ACTH excess in this disorder may induce some activity of 11 beta-hydroxylase, an enzyme not found in the gonads under physiological conditions.
Introduction
The simultaneous evaluation of major urinary steroid metabolites by capillary gas chromatography (1, 2) comprehensively characterizes steroid production in man. Since a differentiation of metabolites derived from adrenocortical or gonadal steroid synthesis is not possible from determinations performed under basal conditions, dynamic tests of adrenocortical function (i.e., stimulation by adrenocorticotropin [ACTH] or suppression by exogenous glucocorticoids) are used to characterize the contribution of the adrenal cortex to overall steroid secretion. The interpretation of the results thus obtained relies on the assumption that these maneuvers interfere with adrenal, but not with gonadal, steroid synthesis. Although it is undisputed that ACTH predominantly influences the function of the adrenal cortex, an additional effect on gonadal steroid production has not yet been excluded. Patients with adrenocortical insufficiency provide an excellent model from which to study the effect of markedly increased endogenous concentrations of ACTH on gonadal steroid production in the absence of functioning adrenocortical tissue. In the present investigation we have compared steroid excretion rates in patients having adrenocortical insufficiency with those of healthy controls, both under basal conditions as well as after additional stimulation with exogenous ACTH 1-24 and after suppression with dexamethasone.
Methods
Healthy subjects. The subjects were five healthy female volunteers, aged [19] [20] [21] [22] [23] [24] [25] [26] [27] yr, who had not taken oral contraceptives for at least 6 mo, and five healthy male volunteers, aged [21] [22] [23] [24] [25] [26] [27] [28] yr. All subjects were within ± 10% oftheir ideal body weight (according to Metropolitan Life Insurance Tables). The aim and potential risks of the investigation were explained to each subject and written consent was obtained in each case. In healthy women, the study was begun between the fifth and the seventh day of the menstrual cycle. Following the collection of a 24-h urine for the determination of steroid excretion, an indwelling catheter was inserted into an antecubital vein and 0.25 mg synthetic ACTH (1-24 ACTH, Synacthen, 0.25 mg = 100 IU; CIBA-GEIGY Ltd. Basle, Switzerland) was administered at 8:00 a.m. as an intravenous bolus. This was followed by a continuous infusion (3 ml/h; t = 8 h) containing 0.25 mg ACTH in 24 ml of 0.9% NaCI solution. On days 3-6 of the experiment the subjects were treated with oral dexamethasone (0.5 mg four times a day; Schering A.G., Berlin, Federal Republic of Germany), but not with intravenous ACTH. A 24-h urine (8:00 a.m.-8:00 p.m.) was collected for the determination of urinary steroid excretion on day 1 (basal), day 2 (ACTH), and day 5 (dexamethasone) of the experiment. Blood samples for the determination of plasma concentrations of cortisol, 21 -deoxycortisol and 11 -ketoandrostenedione, pregnenolone, and 17-hydroxypregnenolone were obtained before the infusion of ACTH. Plasma concentrations of cortisol were also determined after the administration of ACTH and of dexamethasone.
Patients with adrenocortical insufficiency. Six patients with adrenocortical insufficiency (five men, aged 26-48 yr, and one postmenopausal woman, aged 55 yr) consented to participate in the study. '3'I-cholesterol scanning failed in all patients to reveal the presence of functional adrenocortical tissue. Adrenocortical insufficiency was of autoimmune origin in four patients and due to bilateral adrenalectomy for Cushing's disease in two cases. Pituitary surgery had not been performed on any of these patients. The patients had been on continuous glucocorticoid (37.5-50.0 mg cortisone acetate/d divided into two doses) and mineralocorticoid (0.05-0.1 mg 9a-fluoro-hydrocortisone/d) replacement therapy for 2-17 yr before this investigation. Nevertheless, supranormal concentrations of ACTH (> 100-> 1,000 pg/ml; normal <60 pg/ml) were found in each patient when estimated during routine controls on an outpatient basis. For the purpose of this study the patients were admitted to the hospital and taken off their individual substitution therapy. Consecutively, electrolyte equilibrium was monitored daily and maintained by intravenous administration of 0.9% saline. 84 h after the last dose of the respective substitution therapy the patients received an intravenous bolus and an infusion of 1-24 ACTH as described above for the healthy volunteers. Subsequently each patient was given 0.5 mg dexamethasone four times a day and 0.05 mg 9a-fluoro-hydrocortisone/d by mouth for 3 d. A 24-h urine (08:00-08:00 h) for the determination of steroid excretion was collected under basal conditions (i.e., from 60 to 84 h after withdrawal of substitution therapy) during ACTH stimulation and on the third day of reinstituted glucocorticoid (dexamethasone) therapy. Blood samples for the determination of plasma concentrations of cortisol were drawn at the beginning of each urine-collecting period and at the end of the ACTH infusion. Concentrations of ACTH, of 2 1-deoxycortisol, of 11-ketoandrostenedione, ofpregnenolone, and of 1 7-hydroxypregnenolone were obtained before the' infusion of ACTH. Concentrations of ACTH were also estimated after the administration of dexamethasone.
Reference steroids. Reference steroids were purchased from Steraloids Inc., Wilton, NH; and from Makor Chemicals, Jerusalem, Israel. Purity was checked by controlling melting point in each case.
Radioimmunoassays. For the simultaneous radioimmunologic determination ofcortisol, 2 1-desoxycortisol, and 1 1-ketoandrostenedione, 2.0 ml ofplasma were diluted with 8.0 ml H20. [3HJDOC was used to estimate the recovery of 11-ketoandrostenedione, since the latter is not available in a labeled form and shows a chromatographic behavior in the chromatographic system we employed which is identical to that of DOC. Subsequently the samples were extracted with 150 ml of cold CH2Cl2 and the organic extract was washed once with 10 ml ofcold 0.1 N NaOH and twice with 10 ml ofcold H20. Separation of the steroids was achieved by thin-layer chromatography (benzene/ acetone = 75:25). For the simultaneous determihation of pregnenolone and 17-hydroxypregnenolone, 2 ml of plasma were diluted with 8 ml of H20. To determine recoveries 10 with three times 20 ml of ethylacetate and the combined extract was washed once with 20 ml of 0.1 N NaOH and at least twice with 20 ml of double distilled water until neutrality was reached. Anhydrous sodium sulfate (5-10 g) was then added to each sample. After 12 h the solvent was distilled off at 350C at reduced pressure. The residue was transferred with 3 x 1 ml ethylacetate into a centrifuging tube and the solvent was evaporated in a stream of dry nitrogen at 350C.
Derivatization (5, 6). Samples were dissolved in 100 ,d of a solution of methoxyamine hydrochloride (2% in pyridine; Pierce Chemical Co., Rockford, IL) and heated at 80'C for 60 min. After evaporation with dry N2 at 300C, 100 Ml of a mixture of trimethylsilylimidazole, NObis(trimethylsilyl)acetamide, and trimethylchlorosilane (3:3:2, TRI-SIL TBT; Pierce Chemical Co.) was added and the mixture was heated to 60C for 20 h. After evaporation to dryness by dry N2 (250C, overnight), 2 ml of dichloromethane and 1.5 ml of0.1 N H2SO4 were added to each sample, the mixture was shaken, and the aqueous (lighter) phase was pipetted off. The organic layer was washed once with I ml of double distilled water. If the pH of the washing was >7, the organic layer was diluted with 1 ml 0.1 N H2SO4. The organic layer was then diluted with 1 ml CH2Cl2 and washed with H20 until the washings were neutral. Sodium sulfate was added to the organic solutions and the samples were shaken for 20 min and centrifuged. The clear solutions were transferred into reactivials; the solvent was evaporated with dry N2 at room temperatur: and the residue was dissolved in 100 ,l of a mixture of ethylacetate/n-hexane (9:1) containing 100 ng/Al of alkanes n-C24H50 and n-C32H66
Recovery. 20 Ml ofeach sample were measured in a fl-counter (Packard Instruments Co., Delft, Netherlands). Mean recovery (n = 75) was 55.7+5.5%.
Gas chromatography. Gas chromatography was carried out using a Packard Instrument Co. 428 gaschromatograph equipped with a 50 m OV-101 wall-coated open tubular column (0.25 mm i.d., film thickness 0.25 Mm, pretested at 180.000 effective plates), a solid injection device, and a flame ionization detector. N2 was used as a carrier gas with a flow rate of -0.8 ml/min. After sample injection (300°C), the temperature of the oven was immediately programmed between 180°C and 265°C at 0.40C/min followed by an isothermal run for 15 min at end temperature.
Steroid identification. Steroids were identified by comparison of retention times expressed as methylene units as determined by intrapolation between those of the alkanes n-C24H50 and n-C32H66; (Table I) . Trivial names of steroid metabolites determined by gas chromatography and of the other steroids mentioned in this report are given in Table I. Mass spectrometry. Positive identification of I 1-hydroxyandrosterone was attempted by gas chromatography-mass spectrometry using a 5995 gas chromatography-mass spectrometry system equipped with a 25-m fused silica capillary column coated with OV 101 stationary phase (Hewlett-Packard Co., Palo Alto, CA). The GC injector was maintained at 300°C and the oven was programmed from 180°C to 260°C at a rate of I°C/min. Temperatures of the analyzer, transfer line, and ion source were kept at 1800C, 280°C, and 150°C, respectively, and the electron energy was 70 eV. To increase sensitivity it was necessary to determine I Steroid excretion rates of healthy men, healthy women, and of patients with adrenocortical insufficiency are given in Table  II . Comparable excretion rates of cholesterol were found in patients with adrenocortical insufficiency and in healthy controls. Urine samples of patients were characterized by a lack of all 21-hydroxylated metabolites (TH-"A", TH-"B", allo-TH-"B", TH-"DOC", allo-TH-"DOC", TH-"S", allo-TH-"S", TH-"E", allo-TH-"E", TH-"F", allo-TH-"F", a-cortol, f3-cortol, a-cortolone, and fl-cortolone, Fig. 1 ). In addition, patients with adrenocortical insufficiency presented with a reduced excretion ofandrosterone, etiocholanolone, dehydroepiandrosterone, androstenediol, 11 (,-hydroxyetiocholanolone, 1 3l-hydroxyandrosterone, 11 -ketoetiocholanolone, pregnanediol, and allopregnanediol, whereas the mean excretion of pregnanetriol (3.92±3.07 mg/24 h), pregnenetriol (2.22±2.47 mg/24 h), pregnenolone (1.85±2.47 mg/ 24 h), and 1 1-ketoandrosterone (1.34±1.64 mg/24 h) was increased as compared with healthy controls. In regard to the low excretion rates, both in patients with adrenocortical insufficiency and in healthy controls, a comparison of the excreted amounts was not possible for the remaining compounds listed in Tables  I and II . Finally, the excretion rates of cortisol in patients with adrenocortical insufficiency were <0.5 ,ug/24 h after withdrawal of substitution therapy, during stimulation by ACTH, and after 3 d of dexamethasone by mouth. Whereas the administration of ACTH and of dexamethasone induced the expected changes in the excretion of steroid metabolites in healthy men and women, the respective excretion rates remained unchanged in patients with adrenocortical insufficiency (Table II) .
Gas-chromatographic analysis indicated the presence of 11-hydroxyandrosterone in the urine of three patients with adrenocortical insufficiency. This was confirmed by additional mass spectrometry using selected ion monitoring. As shown in Fig. 2 for one single case the chosen characteristic ions were readily identified, both in a mixture of derivatized reference compounds and in the patient's urine.
Discussion
The prerequisite for the simultaneous estimation of a large number of urinary steroid metabolites has been provided by the development of glass capillary gas chromatography (1, 2) . The variety oftechniques and hydrolytic procedures used by different laboratories implies that the only valid reference material is a material obtained using that very method. In order to study the steroid excretion rates in patients with adrenocortical insufficiency, it was therefore pivotal to establish reference data in a group ofhealthy subjects. These data are included in this report.
Although the relative share of the gonads and the adrenal cortex in overall steroid production can easily be studied in patients with adrenocortical insufficiency, few such data have been reported as yet in this disorder (7) (8) (9) .
Under physiological conditions the enzymes 21-hydroxylase, 1 lB-hydroxylase, and 1 8-hydroxylase are unique to the adrenal cortex, whereas other enzymes, such as 3,B-steroid dehydrogenase, 17a-hydroxylase, and the desmolases are shared by the adrenals and by the gonads and probably are controlled by a single gene (10) . The lack of 2 1-hydroxylated steroid metabolites observed in the urine ofour patients can therefore be easily deduced from the differences in the enzymatic equipment ofthe adrenal cortex as compared with that of the gonads, whereas the presence of two 1 1-hydroxylated metabolites, 1 I11B-hydroxyandrosterone and 1 1-ketoandrosterone, and the elevated excretion of pregnenolone, pregnanolone, and pregnenetriol requires further discussion.
Although adrenal scanning is believed to be superior to other noninvasive techniques in the detection of adrenal rest tissue (11), the negative outcome of '311-cholesterol scanning per se may not completely rule out this possibility in our patients. Additional evidence against a residual adrenal function is, however, provided by the lack of urinary cortisol and by plasma cortisol concentrations close to the lower limit of the used radioimmunological method. Finally, the increased excretion of some metabolites not requiring 2 1-hydroxylation (e.g., pregnanetriol and pregnenetriol) in the absence ofall urinary 2 1-hydroxylated metabolites and a similarly distorted relationship among the estimated plasma steroids implies that the site of steroid hormone production in our patients is characterized by a pattern of steroidogenesis different from that of normal adrenal tissue.
In the absence of functional adrenal tissue the presence of 1 1-hydroxylated steroid metabolites must be due to an extraadrenal 1 1-hydroxylase. Such a speculation may be based on the previous demonstration of an extraadrenal 21 -hydroxylase (12) and of a hepatic 313-steroid dehydrogenase (10) . However, in regard to the increased excretion of early steroid metabolites mentioned above, a gonadal origin of 1 l3-hydroxylated steroids in our patients appears more likely. The minor alterations in gonadotropin secretion seen in patients with adrenocortical insufficiency (13) are not likely to account for these pronounced changes in steroid excretion. Under the appropriate experimental conditions, ACTH, the tropic hormone of the adrenal, may stimulate both rat and human testicular cells at the molecular level in terms of RNA syn- PREGNENOLONE (19) '-l177-HYDROXY--DHEA (4) ANDRO;TENEDIOL (6) Figure 1 . Simplified scheme of steroidogenesis in patients with adrenocortical insufficiency. The numbers in brackets refer to the numbering system of steroid standards given in Table I. thesis and of steroid hormone synthesis ( 14) . It (16) (17) (18) (19) . The question of whether these tumors arise from regular testicular tissue (20) or from adrenal remnants within the testes (21) is as yet unsettled (19) , but prolonged exposure to markedly elevated concentrations of ACTH has generally been implied in their pathogenesis (17) . Thus, during prolonged overexposure to ACTH, the human gonad is capable of producing 1 1-hydroxylated steroids.
Since the side chain at C17 found in C21 steroids orients the reduction of the double bond at C4/C5 in the Sf direction (22) , C1903 steroids with the 5:l-configuration (i.e., 1 1-ketoetiocholanolone, and 1 Il3-hydroxyetiocholanolone) are metabolites of C21 precursors such as cortisol. Compounds with the 5a configuration (i.e., 11-ketoandrosterone, 1 (3-hydroxyandrosterone) are derived from 1 l/3-hydroxyandrostenedione and from 1 I-ketoandrostenedione (22-24) via side-chain cleavage of 2 1-deoxycortisol. The synthesis of these steroids, therefore, requires the activity of 1 l3-hydroxylase, but not of 2 1-hydroxylase. The assumed presence of 11 3-hydroxylase in the gonads of our patients thus not only explains the observed excretion of C 1 -oxygenated steroids, but also the preponderance of the 5a-vs. the 5(-configurated metabolites.
The estimated plasma concentrations of 21 -desoxycortisol and 1 -ketoandrosterone are also in keeping with the presence of 1 l-hydroxylase activity in our patients, and it is of note that the reduction in the plasma concentrations of both steroids was less pronounced than that of cortisol. In regard to the elevated excretion rates of 1 -ketoandrosterone, pregnanetriol, pregnenetriol, and pregnenolone, elevated plasma concentrations of the respective precursor steroids (i.e., 1 -ketoandrostenedione, 21-desoxycortisol, pregnenolone, and 17-hydroxypregnenolone) might have been expected. This was clearly not the case and there is no ready explanation for this observation, although one might point out that plasma concentrations of steroids do not necessarily reflect the excretion rates of their metabolites, since both values also depend on the metabolic clearance rate of the respective precursor (25).
Under physiological conditions both the adrenal cortex and the gonads contribute to the urinary excretion of 11 -desoxy-17-ketonic steroid metabolites (etiocholanolone, androsterone), although direct glandular secretion of both compounds is small (26) . In our patients with adrenocortical insufficiency the lack of adrenal precursors apparently accounts for the diminished excretion of etiocholanolone and androsterone. The latter is in keeping with the 65% reduction in plasma androsterone as reported by others (26) .
In conclusion, patients with adrenocortical insufficiency present a pattern of steroid excretion characterized by the complete absence of 2 1-hydroxylated, but not of 1 1-hydroxylated, metabolites. The obtained data suggest that chronic ACTH exposure may result in the activation of 1 1f-hydroxylase in the human gonad.
